A related compound, esketamine, has been approved in the European Union and the United States for the emergency treatment of treatment-resistant depression, administered as a nasal spray under strict ...

MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...